Medical Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China.
Medical Department of Otolaryngology, Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China.
Bioengineered. 2021 Dec;12(1):1189-1201. doi: 10.1080/21655979.2021.1909962.
Long noncoding RNAs (lncRNAs) have been identified as prognostic biomarkers and functional regulators in human tumors. In our study, we aim to investigate the roles of lncRNA SND1-IT1 (SND1-IT1) in retinoblastoma (RB). We observed that SND1-IT1 was highly expressed in both RB specimens and cells, and associated with poorer prognosis of RB patients. Functional investigation revealed that downregulation of SND1-IT1 suppressed RB cell proliferation, migration and invasion and restrained RB tumorigenesis in vivo. MiR-132-3p was predicted to interact with SND1-IT1. RT-qPCR and dual-luciferase reporter assays verified the regulation of miR-132-3p by SND1-IT1 in RB cells. In addition, SND1-IT1 enhanced the expression of SMAD2 by sponging miR-132-3p. Rescue experiments revealed that knockdown of miR-132-3p reversed the inhibiting effects of miR-132-3p knockdown on RB cells. Overall, SND1-IT1 can promote the progression of RB cells through miR-132-3p/SMAD2 axis, suggesting that l SND1-IT1 might be a novel biomarker and potential target for RB.
长链非编码 RNA(lncRNA)已被鉴定为人类肿瘤的预后生物标志物和功能调节剂。在我们的研究中,我们旨在研究 lncRNA SND1-IT1(SND1-IT1)在视网膜母细胞瘤(RB)中的作用。我们观察到 SND1-IT1 在 RB 标本和细胞中均高度表达,并与 RB 患者的预后较差相关。功能研究表明,下调 SND1-IT1 抑制 RB 细胞增殖、迁移和侵袭,并抑制体内 RB 肿瘤发生。miR-132-3p 被预测与 SND1-IT1 相互作用。RT-qPCR 和双荧光素酶报告基因检测验证了 SND1-IT1 在 RB 细胞中对 miR-132-3p 的调控作用。此外,SND1-IT1 通过海绵吸附 miR-132-3p 增强了 SMAD2 的表达。挽救实验表明,miR-132-3p 敲低逆转了 miR-132-3p 敲低对 RB 细胞的抑制作用。总的来说,SND1-IT1 可以通过 miR-132-3p/SMAD2 轴促进 RB 细胞的进展,表明 SND1-IT1 可能是 RB 的一种新的生物标志物和潜在靶点。